These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 16391530)
1. The phantom menace. Rinaldi A EMBO Rep; 2006 Jan; 7(1):14-7. PubMed ID: 16391530 [TBL] [Abstract][Full Text] [Related]
2. [Molecular biology of hepatitis C virus: implications for the development of new therapies and prophylactic vaccine]. Forns X Med Clin (Barc); 2001 Feb; 116(5):191-7. PubMed ID: 11222177 [No Abstract] [Full Text] [Related]
3. [Subgenomic replications of hepatitis C virus (HCV): new possibilities for hepatitis C prophylaxis and treatment]. Puig-Basagoiti F; Sáiz JC Gastroenterol Hepatol; 2001 Dec; 24(10):506-10. PubMed ID: 11730621 [No Abstract] [Full Text] [Related]
4. [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)]. Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D Dtsch Med Wochenschr; 2014 Mar; 139(13):655-9. PubMed ID: 24648178 [No Abstract] [Full Text] [Related]
6. Hepatitis C. el-Sayed AM; Sharara AI J Med Liban; 2001; 49(2):71-7. PubMed ID: 11910970 [No Abstract] [Full Text] [Related]
7. The American Association For the Study of Liver Diseases: new perspectives in the treatment of hepatitis C. Zeuzem S Antivir Ther; 2006; 11(2):267-71. PubMed ID: 16640108 [No Abstract] [Full Text] [Related]
9. Hepatitis C virus: current concepts and future challenges. Klenerman P; Gupta PK QJM; 2012 Jan; 105(1):29-32. PubMed ID: 22123990 [No Abstract] [Full Text] [Related]
10. Recommendations for the management of prevention of vertical HBV and HCV infection. Pawłowska M; Sobolewska-Pilarczyk M Przegl Epidemiol; 2016; 70(1):33-4, 119-20. PubMed ID: 27344471 [No Abstract] [Full Text] [Related]
11. The unsung heroes of the Nobel-winning hepatitis C discovery. Ledford H Nature; 2020 Oct; 586(7830):485. PubMed ID: 33082542 [No Abstract] [Full Text] [Related]
12. New therapeutic options for hepatitis C. Waters L; Nelson M Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339 [TBL] [Abstract][Full Text] [Related]
14. A public health approach to hepatitis C control in low- and middle-income countries. Suthar AB; Harries AD PLoS Med; 2015 Mar; 12(3):e1001795. PubMed ID: 25757228 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C: a new horizon. Chang KM Gastroenterology; 2006 Dec; 131(6):1667-8. PubMed ID: 17188957 [No Abstract] [Full Text] [Related]
16. Viral hepatitis at a crossroad. Lok AS; Pawlotsky JM Gastroenterology; 2012 May; 142(6):1261-3. PubMed ID: 22537431 [No Abstract] [Full Text] [Related]
17. Rethinking hepatitis C viral kinetics: Insights into host-virus interactions in 'difficult-to-treat' groups and implications for novel treatment approaches. Yeung E; Chung RT J Hepatol; 2005 Nov; 43(5):748-50. PubMed ID: 16171895 [No Abstract] [Full Text] [Related]
18. Strategies for hepatitis C therapeutic intervention: now and next. Tan SL; He Y; Huang Y; Gale M Curr Opin Pharmacol; 2004 Oct; 4(5):465-70. PubMed ID: 15351350 [TBL] [Abstract][Full Text] [Related]
19. MEDICINE. Global control of hepatitis C virus. Cox AL Science; 2015 Aug; 349(6250):790-1. PubMed ID: 26293940 [No Abstract] [Full Text] [Related]